Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Trillium Therapeutics Inc. T.TRIL

Healthcare Biotechnology
Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.

TSX:TRIL - Post Discussion

Trillium Therapeutics Inc. > IS SOMETHING UP BEHIND THE SCENES?
View:
Post by Stockemups on Feb 28, 2020 12:20pm

IS SOMETHING UP BEHIND THE SCENES?

This is a massive run up.
Comment by birch1 on Feb 28, 2020 2:19pm
you saw the nr. no news. down we go.
Comment by CleverInvestor2 on Feb 28, 2020 5:12pm
Not necessarily. The NR is the offer Forty Seven might get from Gilead.... It's like the marijuana stocks when Canopy Growth and Cronos Group announced deals,(Constellation and Altria respectively) they all went up together. What really got investors hitting the bid today is the potential for Trillium to grow. There market cap is a fraction of Forty Seven, if they're successful, we can ...more  
Comment by burnout29 on Feb 29, 2020 11:02am
This post has been removed in accordance with Community Policy
Trillium Therapeutics Inc.